The e-SELECT Registry a MULTICENTER POST-MARKET SURVEILLANCE "A multicenter prospective observational registry of the CYPHER SELECT Sirolimus- eluting Coronary Stent and of all future generation of commercially approved Cordis Sirolimus- eluting Stents."

Trial Profile

The e-SELECT Registry a MULTICENTER POST-MARKET SURVEILLANCE "A multicenter prospective observational registry of the CYPHER SELECT Sirolimus- eluting Coronary Stent and of all future generation of commercially approved Cordis Sirolimus- eluting Stents."

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms E-SELECT
  • Sponsors Cordis Corporation
  • Most Recent Events

    • 25 Aug 2011 Official Title amended, Company added as trial sponsor as reported by Clinical Trials Registry - India.
    • 03 Feb 2010 New source identified and integrated (Clinical Trials Registry - India, CTRI2008-091-000170).
    • 17 Dec 2009 Planned number of patients changed from 30000 to 15000 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top